RMRonald Justin Md Mistovich

Ronald Justin Md Mistovich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ronald Justin Md Mistovich has a total of 179 co-authors. Here are the top co-authors by number of shared publications:

  • Robert J. Burkhart

    Department of Orthopaedic Surgery, University Hospitals, Cleveland, OH, USA

    7 shared publications
  • Peter D. Fabricant

    Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York, USA

    5 shared publications
  • Allison Gilmore

    Case Western Reserve, University Hospitals, Cleveland Medical Center, Cleveland, Ohio, USA

    4 shared publications
  • David A. Kolin

    Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York, USA

    4 shared publications
  • David C. Kaelber

    Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University and Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio, USA

    4 shared publications
  • George H. Thompson

    Division of Pediatric Orthopaedic Surgery, Rainbow Babies and Children’s Hospital, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, USA

    4 shared publications

Latest Publications

  • Novel All-Suture Repair Construct for Adolescent Triceps Sleeve Fracture

    by Tony Ezzat, Priya L. Jayakumar, Morgan B. Weber, R. Justin Mistovich, Elizabeth A. Simmons

    Case: An 18-year-old athletic female presented with a distal triceps sleeve avulsion fracture. To safely stabilize this small avulsion without risking implant cutout or iatrogenic comminution, we used a novel all-suture–based technique. Her fracture healed well, and she subsequently was able to return to all activities without complication. Conclusion: No consensus exists regarding the optimal fixation technique for distal triceps-olecranon bony avulsions. This case report demonstrates success using an all-suture–based fixation technique, which can be used when a bony fragment is not amenable to other traditional fixation strategies.

  • Open Access

    Quantifying Risk Factors for Osteochondritis Dissecans in Children: A Propensity-Matched Retrospective Cohort Study

    by Joseph A. Magoline, Daniel F. Wagner, David C. Kaelber, R. Justin Mistovich

    Background: Osteochondritis dissecans (OCD) is a developmental orthopaedic condition in pediatric patients characterized by disruption of epiphyseal cartilage vascular supply leading to secondary subchondral bone changes and potential joint degeneration. While repetitive trauma is implicated, emerging evidence suggests a contributing role of biological and hereditary risk factors. Purpose: To quantify the relative risk (RR) of OCD with specific biological comorbidities and athletic participation in a large representative pediatric and adolescent population. Study Design: Cross-sectional study; Level of evidence, 3. Methods: We queried the TriNetX US Collaborative Network for patients aged ≤25 years between 2017 and 2024. Using International Classification of Diseases (ICD-10) diagnosis codes, we identified patients with potentially associated medical conditions (eg, hypopituitarism, vitamin D deficiency, coagulopathies, obesity, and nicotine dependence) and participation in common youth sports. The RR of OCD development for each condition and sport was calculated after propensity matching on age and sex. Annual incidence and prevalence were also assessed. Results: We identified 18,493 patients with OCD (mean age at first ICD diagnosis: 13.4 ± 3.45 years; 59% male). The most common OCD location was the knee (49%). From 2017 to 2024, the annual incidence rose from 15 to 23 per 100,000. Gymnastics (RR, 4.96; [95% CI, 3.14-7.83]), volleyball (RR, 2.96 [95% CI, 1.84-4.74]), and cheerleading (RR, 2.83 [95% CI, 1.47-5.47]) were associated with the highest OCD risk among included sports. Among medical comorbidities, primary thrombophilia (RR, 3.20 [95% CI, 1.57-6.51]), von Willebrand Factor deficiency (RR, 2.90 [95% CI, 1.41-5.95]), and Factor V Leiden (RR, 2.70 [95% CI, 1.31-5.58]) carried the highest risk. Hypopituitarism (RR, 1.71 [95% CI, 1.21-2.41]) and body mass index ≥35kg/m 2 (RR, 1.14 [95% CI, 1.01-1.29]) were also significantly associated. Nicotine dependence was associated with decreased risk (RR, 0.72 [95% CI, 0.57-0.91]). Conclusion: This large-scale analysis provides updated epidemiologic trends and quantifies risk factors associated with pediatric OCD. Age, sex, specific medical conditions, and athletic participation were linked to increased OCD risk, and novel associations between OCD and coagulopathies were identified.

  • Epidemiological Trends and Projections of Adolescent Idiopathic Scoliosis Patients Among 118 Thousand Patients

    by Parshva A. Sanghvi, Robert J. Burkhart, Rayyan Abid, Alexander N. Berk, Jeremy M. Adelstein, Andrew J. Moyal, Michael P. Glotzbecker, R. Justin Mistovich

    Introduction: Suspected changes in adolescent idiopathic scoliosis (AIS) demographic distribution compared with historical cohorts emphasize the need for an updated understanding of epidemiological trends. We aimed to characterize AIS trends in the United States from 2016 to 2023, compare these findings with historical cohorts, and project trends through 2030. Methods: AIS cases from 2016 to 2023 were identified using the TriNetX US Collaborative platform. A subanalysis examined patients who underwent posterior spinal fusion (PSF) and cases during the COVID-19 pandemic. Primary outcomes included prevalence, incidence proportion (IP), and incidence rate (IR). Historical AIS cohorts were identified through a systematic search. Regression modeling projected trends to 2030. Results: In 2023, the TriNetX platform reported a notable rise in AIS prevalence of 110 cases per 100,000 patients compared with 2016 ( P < 0.05). The IP and IR of AIS also rose, with 14,733 additional cases identified in 2023. PSF occurred in 5,990 cases per 100,000 AIS patients. Female patients had higher AIS prevalence than male patients (140 vs. 71.3 cases per 100,000) and higher PSF prevalence (6,400 vs. 5,350 cases per 100,000 AIS patients) in 2023. Incidence of AIS was markedly lower compared with historical cohorts; however, the female-to-male ratio was comparable. The most marked decrease (16.52% decrease from 2019 to 2020) and increase (22.15% increase from 2020 to 2021) in cases occurred during the COVID-19 pandemic. Regression analysis indicated linear increases in both AIS and PSF, projecting a national AIS prevalence of 17,000 cases per 100,000 patients nationally and PSF prevalence among AIS patients of 10,230 cases per 100,000 patients by 2030. Conclusion: These findings highlight rising national rates of AIS diagnoses and PSF procedures among AIS patients. Further research is warranted on the etiology underlying increased incidence of AIS in male patients and potential healthcare burdens associated with projected increases in AIS prevalence.


  • Open Access

    Operative Versus Nonoperative Treatment of Medial Patellofemoral Ligament Injuries: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis

    by Shiv Patel, Omkar S. Anaspure, Anthony N. Baumann, Troy M. Manz, R. Justin Mistovich

    Background: The medial patellofemoral ligament (MPFL) serves as a major stabilizer in the knee, providing restraint against lateral patellar translation. The optimal approach for treating patients with first-time MPFL injuries remains uncertain, as the choice between operative and nonoperative treatment depends on the risks and variability associated with individual patient anatomy, activity, and presentation. Purpose: To evaluate high-level literature on outcomes after operative and nonoperative treatment of MPFL injuries to guide decision-making. Study Design: Meta-analysis; Level of evidence, 1. Methods: This systematic review and meta-analysis utilized PubMed, CINAHL, MEDLINE, Web of Science, and SPORTDiscus through November 25, 2024, to find randomized controlled trials that assess the outcomes associated with operative versus nonoperative treatment for MPFL tears. The primary outcomes were rates of recurrent dislocation and patient-reported outcomes. Statistical analysis included relative risk (RR) with 95% confidence intervals (95% CIs) along with trial sequential analysis (TSA) and assessment of fragility index. Results: A total of 306 patients (55.9% female) had a frequency-weighted mean ± SD age of 19.68 ± 4.24 years (range, 9-40) and follow-up time of 21.61 ± 5.34 months and underwent nonoperative (n = 147) or operative (n = 159) treatment. When compared with nonoperative treatment, operative treatment had a significantly lower rate of recurrent instability (10.69% vs 29.93%; RR, 2.49; 95% CI, 1.34-4.61; P = .004) with robust evidence (fragility index, 7 patients) but no difference in Kujala scores (79.02 ± 10.71 vs 88.78 ± 2.91; overall mean difference, –9.32; 95% CI, –19.45 to 0.81; P = .071). Subgroup analysis showed that repair had a significantly lower rate of recurrent instability as compared with nonoperative treatment (15.74% vs 35.42%; RR, 1.87; 95% CI, 1.11-3.17; P = .019). Similarly, reconstruction showed a significantly lower rate of recurrent instability as compared with nonoperative treatment (3.92% vs 33.33%; RR, 6.80; 95% CI, 1.93-23.95; P = .003). TSA for all primary outcomes demonstrated that the Z curve did not cross the required information size, suggesting that the current volume of data is not sufficient to draw definitive conclusions for each comparison. Conclusion: Operative treatment of MPFL injuries resulted in a robust and significantly lower rate of recurrent instability when compared with nonoperative treatment, although there was no difference in Kujala scores. Given the current evidence, operative treatment appears to be the more ideal approach to treating first-time patellar dislocations. However, the key to these findings is the need for further studies, as TSA showed that the current level of evidence is insufficient to draw definitive conclusions.

  • Recalls of Arthroscopic Equipment After Food and Drug Administration 510(k) Approval: A Twenty-Year Analysis of Causes, Trends, and Time to Recall (2004 to 2024)

    by Thriaksh Rajan, Christian J. Hecht, Comron Saifi, Prem N. Ramkumar, R. Justin Mistovich

    Background: Current reliance on the expedited 510(k) approval pathway has driven rapid commercial availability of novel arthroscopic devices. Despite the low complication rates of arthroscopic procedures, products from this pathway are suspected to increase the rate of recalls and device malfunctions. Purpose: This study aimed to characterize arthroscopic device recalls, analyze trends in recall incidence, and identify predictors of time to recall. Methods: A 20-year, retrospective, cross-sectional study was conducted using the Food and Drug Administration (FDA) Recalls database. Recalled devices approved under the FDA 510(k) pathway were identified and categorized by type, manufacturer, recall class, and cause. Statistical analyses included Poisson regression for trends and Cox proportional hazards modeling for predictors of time to recall. Results: A total of 124 recalls were initiated during the study period (average 6.2 recalls/year), with packaging and process control issues accounting for 50.7% of recalls. Recall incidence remained stable over time, although nearly half occurred in 2008, 2010, 2012, and 2019. Mean recall time was 491 days (95% confidence interval [CI], 444 to 539). Devices recalled due to material/implant contamination had markedly shorter times (HR: 3.73 [95% CI, 1.78 to 7.82]), whereas process control issues prolonged recall times (HR: 0.56 [95% CI, 0.31 to 1.00]). Manufacturer was another predictor of time to recall, with one manufacturer exhibiting substantially extended recall times (HR: 0.45 [95% CI, 0.22 to 0.92]). Conclusion: Arthroscopic device recalls are largely caused by packaging and process control issues, emphasizing the need for stricter quality assurance during manufacturing. Although recall incidence remained stable over the past two decades, variability in recall times highlights opportunities for improved manufacturer accountability and FDA oversight. Increasing procurement scrutiny, enhancing FDA audit practices, and integrating recall data with clinical outcomes can minimize disruptions in arthroscopic surgery. Level of Evidence: Level III Therapeutic Study.